Eyebright Medical Technology Beijing Co Ltd (688050) — Capital Reinvestment Ratio
Eyebright Medical Technology Beijing Co Ltd (688050) has a Capital Reinvestment Ratio of 0.28x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥76.92 Million) in capital expenditures (CN¥21.37 Million). Check Eyebright Medical Technology Beijing Co (688050) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eyebright Medical Technology Beijing Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Eyebright Medical Technology Beijing Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Eyebright Medical Technology Beijing Co (688050) cash conversion ratio.
Annual Capital Reinvestment Ratio for Eyebright Medical Technology Beijing Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Eyebright Medical Technology Beijing Co Ltd from 2017 to 2025. See Eyebright Medical Technology Beijing Co free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥369.15 Million | CN¥123.14 Million | ▼ -64.8% |
| 2024 | 0.95x | CN¥347.75 Million | CN¥329.48 Million | ▼ -42.1% |
| 2023 | 1.64x | CN¥226.27 Million | CN¥370.34 Million | ▲ +51.1% |
| 2022 | 1.08x | CN¥250.13 Million | CN¥271.03 Million | ▼ -23.6% |
| 2021 | 1.42x | CN¥219.30 Million | CN¥311.22 Million | ▲ +47.4% |
| 2020 | 0.96x | CN¥123.35 Million | CN¥118.73 Million | ▼ -65.7% |
| 2019 | 2.80x | CN¥50.49 Million | CN¥141.61 Million | ▲ +24.3% |
| 2018 | 2.26x | CN¥31.82 Million | CN¥71.81 Million | ▼ -70.3% |
| 2017 | 7.60x | CN¥4.15 Million | CN¥31.53 Million | — |